Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates

Nature Communications

Volumn 3, Issue , 2012, Pages

  Du, Yang ^a   Yang, Marie ^a   Wei, Wei ^a   Huynh, Hoang Dinh ^a   Herz, Joachim ^b   Saghatelian, Alan ^b   Wan, Yihong ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP VII; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ALOPECIA; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; GENE DELETION; GROWTH RETARDATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

MAMMALIA; MUS;

EID: 84866085491     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2011     Document Type: Article

References (39)

1. Walker, A. Breast milk as the gold standard for protective nutrients. J. Pediatr. 156, S3-S7 (2010).
2. Caplan, M. S., Sun, X. M., Hseuh, W. & Hageman, J. R. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J. Pediatr. 116, 960-964 (1990). (Pubitemid 20201711)
3. Furukawa, M., Narahara, H., Yasuda, K. & Johnston, J. M. Presence of platelet-activating factor-acetylhydrolase in milk. J. Lipid Res. 34, 1603-1609 (1993). (Pubitemid 23264333)
4. Moya, F. R. et al. Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report. J. Pediatr. Gastroenterol. Nutr. 19, 236-239 (1994). (Pubitemid 24299635)
5. Tacken, P. J., Hofker, M. H., Havekes, L. M. & van Dijk, K. W. Living up to a name: the role of the VLDL receptor in lipid metabolism. Curr. Opin. Lipidol. 12, 275-279 (2001). (Pubitemid 32521952)
6. Trommsdorff, M. et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701 (1999). (Pubitemid 29278044)
7. D'Arcangelo, G. et al. Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479 (1999).
8. D'Arcangelo, G. et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719-723 (1995).
9. Saghatelian, A. & Cravatt, B. F. Global strategies to integrate the proteome and metabolome. Curr. Opin. Chem. Biol. 9, 62-68 (2005). (Pubitemid 40208626)
10. Saghatelian, A. & Cravatt, B. F. Assignment of protein function in the postgenomic era. Nat. Chem. Biol. 1, 130-142 (2005).
11. Vinayavekhin, N., Homan, E. A. & Saghatelian, A. Exploring disease through metabolomics. ACS Chem. Biol. 5, 91-103 (2010).
12. Saghatelian, A. et al. Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43, 14332-14339 (2004). (Pubitemid 39491967)
13. Wan, Y. et al. Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk. Genes Dev. 21, 1895-1908 (2007). (Pubitemid 47204929)
14. Tjoelker, L. W. et al. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374, 549-553 (1995).
15. Khialeeva, E., Lane, T. F. & Carpenter, E. M. Disruption of reelin signaling alters mammary gland morphogenesis. Development 138, 767-776 (2011).
16. Stein, T. et al. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am. J. Pathol. 177, 2323-2333 (2010).
17. Trommsdorff, M., Borg, J. P., Margolis, B. & Herz, J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560 (1998). (Pubitemid 29005740)
18. Howell, B. W., Lanier, L. M., Frank, R., Gertler, F. B. & Cooper, J. A. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol. 19, 5179-5188 (1999). (Pubitemid 29289556)
19. Morris, S. M. & Cooper, J. A. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2, 111-123 (2001). (Pubitemid 32219864)
20. Tessner, T. G., O'Flaherty, J. T. & Wykle, R. L. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J. Biol. Chem. 264, 4794-4799 (1989). (Pubitemid 19092885)
21. Casals-Stenzel, J., Franke, J., Friedrich, T. & Lichey, J. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist. Br. J. Pharmacol. 91, 799-802 (1987). (Pubitemid 17128165)
22. Boycott, K. M. et al. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am. J. Hum. Genet. 77, 477-483 (2005). (Pubitemid 41192653)
23. Helbecque, N. et al. VLDL receptor polymorphism, cognitive impairment, and dementia. Neurology 56, 1183-1188 (2001). (Pubitemid 32405712)
24. Moheb, L. A. et al. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome. Eur. J. Hum. Genet. 16, 270-273 (2008).
25. Okuizumi, K. et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat. Genet. 11, 207-209 (1995).
26. Ozcelik, T. et al. Mutations in the very low-density lipoprotein receptor VLDLR cause cerebellar hypoplasia and quadrupedal locomotion in humans. Proc. Natl Acad. Sci. USA 105, 4232-4236 (2008). (Pubitemid 351754363)
27. Turkmen, S. et al. Cerebellar hypoplasia, with quadrupedal locomotion, caused by mutations in the very low-density lipoprotein receptor gene. Eur. J. Hum. Genet. 16, 1070-1074 (2008).
28. Near, S. E., Wang, J. & Hegele, R. A. Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene. J. Hum. Genet. 46, 490-493 (2001). (Pubitemid 32744124)
29. Yagyu, H. et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037-10043 (2002). (Pubitemid 34968113)
30. Claud, E. C., Li, D., Xiao, Y., Caplan, M. S. & Jilling, T. Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers. Res. 52, 155-162 (2002). (Pubitemid 34827234)
31. Kald, B., Smedh, K., Olaison, G., Sjodahl, R. & Tagesson, C. Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease. Digestion 57, 472-477 (1996). (Pubitemid 26385299)
32. Miwa, M. et al. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82, 1983-1991 (1988). (Pubitemid 19054946)
33. Packard, C. J. et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 343, 1148-1155 (2000).
34. Stafforini, D. M. et al. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97, 2784-2791 (1996). (Pubitemid 26197091)
35. Wilensky, R. L. et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat. Med. 14, 1059-1066 (2008).
36. Gdalevich, M., Mimouni, D., David, M. & Mimouni, M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J. Am. Acad. Dermatol. 45, 520-527 (2001). (Pubitemid 32917245)
37. Demos, C., Bandyopadhyay, M. & Rohrer, B. Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models. Mol. Vis. 14, 1639-1649 (2008).
38. Haines, J. L. et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest. Ophthalmol. Vis. Sci. 47, 329-335 (2006). (Pubitemid 46780832)
39. Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L. & Herz, J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 8453-8457 (1995).